Johns Hopkins ABX Guide
Sodium Stibogluconate
INDICATIONS
FDA
FDA
- Not FDA-approved/commercially available in the U.S.
- Available from the CDC under an IND protocol: http://www.cdc.gov/laboratory/drugservice/formulary.html#sodium
- CDC’s IND protocol covers IV and IM administration (not intralesional).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Cutaneous, visceral, and mucosal leishmaniasis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 15, 2022
Citation
Avdic, Edina, and Paul G Auwaerter. "Sodium Stibogluconate." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540510/all/Sodium_Stibogluconate.
Avdic E, Auwaerter PG. Sodium Stibogluconate. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540510/all/Sodium_Stibogluconate. Accessed July 20, 2025.
Avdic, E., & Auwaerter, P. G. (2022). Sodium Stibogluconate. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540510/all/Sodium_Stibogluconate
Avdic E, Auwaerter PG. Sodium Stibogluconate [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2025 July 20]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540510/all/Sodium_Stibogluconate.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sodium Stibogluconate
ID - 540510
A1 - Avdic,Edina,Pharm.D.
AU - Auwaerter,Paul,M.D.
Y1 - 2022/10/15/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540510/all/Sodium_Stibogluconate
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
